CCR2 and inflammatory bowel disease: For example, in inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis, the normal differentiation trajectory is disrupted as intestinal macrophages retain their immature CCR2+ pro-inflammatory phenotype instead of differentiating into CCR2− anti-inflammatory/resident macrophages [17, 19, 25].